8-K - Acumen Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Management Change

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On November 6, 2025, the Board of Directors (the “ Board

Management Change

$40.0K

7.01

, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the

Regulation Fd

9.01

Financial Statements and Exhibits. (d). Exhibits Exhibit No. Description 99.1 Press Release, dated November 10, 2025 104 Cover Page Interactive Data File (embed

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1